Live Breaking News & Updates on Grand Yangtze Capital
Stay updated with breaking news from Grand yangtze capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
China Digest: Sequoia backs Neurophth; TransThera bags over $50m February 9, 2021 Wuhan Neurophth Biological Technology has secured 400 million yuan ($62 million) in a Series B round of financing jointly led by Guofang FOF and InnoVision Capital, while Nanjing TransThera Biosciences has garnered over $50 million led by Co-Stone Asset Management. Sequoia backs gene therapy company Neurophth Chinese ophthalmic gene therapy technology company Wuhan Neurophth Biological Technology Co., Ltd has secured 400 million yuan ($62 million) in a Series B round of financing, according to a company statement on Tuesday. The fresh round was co-led by Shanghai International Group’s Guofang FOF and Greater China-focused PE firm InnoVision Capital, while new investors including Oriza Holdings, Grand Mount Capital, and Yuanfeng Capital joined the round. ....